Literature DB >> 24707514

Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24707514

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  27 in total

Review 1.  Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review.

Authors:  Arnaud G L'Huillier; Deepali Kumar
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Circulation of influenza B lineages in northern Viet Nam, 2007-2014.

Authors:  Thi Thanh Le; Thu Hang Pham; Thi Hien Pham; Le Khanh Hang Nguyen; Co Thach Nguyen; Vu Mai Phuong Hoang; Thu Huong Tran; Vu Son Nguyen; Huong Giang Ngo; Quynh Mai Le
Journal:  Western Pac Surveill Response J       Date:  2015-11-11

3.  Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Authors:  Luzhao Feng; Peng Yang; Tao Zhang; Juan Yang; Chuanxi Fu; Ying Qin; Yi Zhang; Chunna Ma; Zhaoqiu Liu; Quanyi Wang; Genming Zhao; Hongjie Yu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Influenza vaccination: in the UK and across Europe.

Authors:  Simon de Lusignan; Ana Correa; Joanna Ellis; Richard Pebody
Journal:  Br J Gen Pract       Date:  2016-09       Impact factor: 5.386

5.  Environmental Stability of Swine and Human Pandemic Influenza Viruses in Water under Variable Conditions of Temperature, Salinity, and pH.

Authors:  R L Poulson; S M Tompkins; R D Berghaus; J D Brown; D E Stallknecht
Journal:  Appl Environ Microbiol       Date:  2016-06-13       Impact factor: 4.792

6.  Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.

Authors:  Björn F Koel; Ramona Mögling; Salin Chutinimitkul; Pieter L Fraaij; David F Burke; Stefan van der Vliet; Emmie de Wit; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Derek J Smith; Ron A M Fouchier; Miranda de Graaf
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

7.  The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children.

Authors:  Emmanuel B Walter; Christoph P Hornik; Lisa Grohskopf; Charles E McGee; Christopher A Todd; Oidda I Museru; Lynn Harrington; Karen R Broder
Journal:  Vaccine       Date:  2017-10-19       Impact factor: 3.641

8.  Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.

Authors:  Jorge M Dinis; Kelsey R Florek; Omolayo O Fatola; Louise H Moncla; James P Mutschler; Olivia K Charlier; Jennifer K Meece; Edward A Belongia; Thomas C Friedrich
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

9.  Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

Authors:  Brendan Flannery; Richard K Zimmerman; Larisa V Gubareva; Rebecca J Garten; Jessie R Chung; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Suzanne E Ohmit; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Pedro A Piedra; Vasiliy P Mishin; Anton P Chesnokov; Sarah Spencer; Swathi N Thaker; John R Barnes; Angie Foust; Wendy Sessions; Xiyan Xu; Jacqueline Katz; Alicia M Fry
Journal:  J Infect Dis       Date:  2016-05-06       Impact factor: 7.759

10.  An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.

Authors:  Kelsey R Florek; Luiza M Campos; Katarina M Braun; Huong Q McLean; Jennifer P King; Brendan Flannery; Edward A Belongia; Thomas C Friedrich
Journal:  Vaccine       Date:  2017-12-15       Impact factor: 4.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.